Literature DB >> 18209070

NK cells lyse T regulatory cells that expand in response to an intracellular pathogen.

Sugata Roy1, Peter F Barnes, Ankita Garg, Shiping Wu, David Cosman, Ramakrishna Vankayalapati.   

Abstract

We evaluated the capacity of NK cells to influence expansion of CD4(+)CD25(+)FoxP3(+) regulatory T cells (Tregs) in response to microbial Ags, using Mycobacterium tuberculosis as a model. We previously found that Tregs expand when CD4(+) cells and monocytes are exposed to M. tuberculosis. Addition of NK cells that were activated by monokines (IL-12, IL-15, and IL-18) or by exposure to M. tuberculosis-stimulated monocytes reduced Treg expansion in response to M. tuberculosis. NK cell inhibition of Treg expansion was not mediated through IFN-gamma. Activated NK cells lysed expanded, but not freshly isolated Tregs. Although monokines increased NK cell expression of the activating receptors NKp46, NKG2D, 2B4, CD16, and DNAM-1, only anti-NKG2D and anti-NKp46 inhibited NK cell lysis of expanded Tregs. Of five NKG2D ligands, only UL16-binding protein 1 (ULBP1) was up-regulated on M. tuberculosis-expanded Tregs, and anti-ULBP1 inhibited NK cell lysis of expanded Tregs. M. tuberculosis-stimulated monocytes activated NK cells to lyse expanded Tregs, and this was also inhibited by anti-NKG2D and anti-ULBP1, confirming the physiological relevance of this effect. Our study identifies a potential new role for NK cells in maintaining the delicate balance between the regulatory and effector arms of the immune response.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18209070     DOI: 10.4049/jimmunol.180.3.1729

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  67 in total

Review 1.  An overview on non-T cell pathways in transplant rejection and tolerance.

Authors:  Wentao Liu; Xian C Li
Journal:  Curr Opin Organ Transplant       Date:  2010-08       Impact factor: 2.640

Review 2.  Learning to live together: harnessing regulatory T cells to induce organ transplant tolerance.

Authors:  Andrew Y Chang; Nupur Bhattacharya
Journal:  Yale J Biol Med       Date:  2011-12

Review 3.  An update on regulatory T cells in transplant tolerance and rejection.

Authors:  Xian Chang Li; Laurence A Turka
Journal:  Nat Rev Nephrol       Date:  2010-08-03       Impact factor: 28.314

Review 4.  Boosting vaccine efficacy the natural (killer) way.

Authors:  Carolyn E Rydyznski; Stephen N Waggoner
Journal:  Trends Immunol       Date:  2015-08-10       Impact factor: 16.687

5.  Cancer immunotherapy using a bispecific NK receptor fusion protein that engages both T cells and tumor cells.

Authors:  Tong Zhang; Charles L Sentman
Journal:  Cancer Res       Date:  2011-01-31       Impact factor: 12.701

Review 6.  Natural killer cells in immunodefense against infective agents.

Authors:  Nicolas Zucchini; Karine Crozat; Thomas Baranek; Scott H Robbins; Marcus Altfeld; Marc Dalod
Journal:  Expert Rev Anti Infect Ther       Date:  2008-12       Impact factor: 5.091

7.  NK-dependent increases in CCL22 secretion selectively recruits regulatory T cells to the tumor microenvironment.

Authors:  Adam W Mailloux; M Rita I Young
Journal:  J Immunol       Date:  2009-03-01       Impact factor: 5.422

8.  Interleukin-21 Regulates Natural Killer Cell Responses During Mycobacterium tuberculosis Infection.

Authors:  Padmaja Paidipally; Deepak Tripathi; Abhinav Van; Rajesh Kumar Radhakrishnan; Rohan Dhiman; Sambasivan Venkatasubramanian; Kamakshi P Devalraju; Amy R Tvinnereim; Vijaya Lakshmi Valluri; Ramakrishna Vankayalapati
Journal:  J Infect Dis       Date:  2018-03-28       Impact factor: 5.226

Review 9.  Regulatory NK-cell functions in inflammation and autoimmunity.

Authors:  Anna Lünemann; Jan D Lünemann; Christian Münz
Journal:  Mol Med       Date:  2009-05-11       Impact factor: 6.354

10.  Beyond Stressed Self: Evidence for NKG2D Ligand Expression on Healthy Cells.

Authors:  Robert A Eagle; Insiya Jafferji; Alexander D Barrow
Journal:  Curr Immunol Rev       Date:  2009-02
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.